Summary The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium
(CPTAC) investigates tumors from a proteogenomic perspective, creating rich multi-omics …

Glycoproteomics is a rapidly growing field that aims to identify and characterize protein
glycosylation events at a system level. However, the analysis of protein glycosylation in …

Nanostructured devices and nanoparticles have fundamentally reshaped the development
of precision healthcare in recent decades. Meanwhile, mass spectrometry (MS)-based …

N-linked protein glycosylation is a key regulator in various biological functions. Previous
studies have shown that aberrant glycosylation is associated with many diseases. Therefore …

Surfaces engineered to identify and enrich glycoproteins are of considerable interest in the
diagnostic and detection fields. A boronate affinity (BA) material was proposed as a potential …

Prostate cancer (PC) is a leading cause of morbidity and mortality among men worldwide.
Molecular biomarkers work in conjunction with existing clinicopathologic tools to help …

Background Prostate cancer (PCa) is one of the most common tumors and the second
leading cause of cancer-related death in men. The discovery of novel biomarkers for PCa …

Simple Summary Prostate cancer is a heterogeneous disease and a major cause of cancer
deaths worldwide. The most widely used prostate cancer biomarker, prostate-specific …

Abstract Background Prostate Cancer (PCa) represents the second leading cause of cancer-
related death in men. Prostate-specific antigen (PSA) serum testing, currently used for PCa …

Identifying molecular alterations occurring during cancer progression is essential for a
deeper understanding of the underlying biological processes. Here we have analyzed …